BLI analysis of femurs, tibiae, and spleens on day 22 revealed impeded AML engraftment in CD33-CAR-NK-treated mice while the administration of UTD-NK cells did not have any effect. This evidence concerns the gene CD33 and acute myeloid leukemia.